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Both  early  membrane  changes  and  immune  cell  activation 
that  can  eventually  lead  to  nuclear  DNA  degradation  occur 
during oxidative stress. This release of reactive oxygen species can 
contribute significantly to a wide range of disorders throughout 
the body. In many scenarios, the inciting event may be the activa-
tion of only one system in the body, such as the immune system. 
For example, one can consider the role of microglia in the brain.   
One  function  of  microglia  is  to  remove  injured  neurons  and 
vascular cells in the brain. The role of microglia in the brain also 
becomes broader to form a barrier for the removal of foreign cells, 
such as infectious microorganisms, from the brain’s parenchyma 
to allow for subsequent tissue repair. However as microglia func-
tion to quarantine cells for removal, they also can rely upon the 
generation of reactive oxygen species and the release of cytokines 
that may lead to the demise of previously unaffected “by-stander” 
cells. Given the complexity of even a single cellular population,   
it  becomes  critical  for  the  development  of  new  therapeutic   
strategies  to  focus  upon  novel  studies  directed  to  merge  the 
understanding of cellular biology with the data acquired through 
prospective clinical trials.
In  this  issue  of  Oxidative  Medicine  and  Cellular  Longevity, 
we provide for our readers a number of new insights that blend 
unique cellular pathways with the prediction and possibilities for 
successful clinical care in disorders impacted by oxidative stress. 
Maiese et al. bring into focus the consideration of strategies that 
control the modulation of a host of cellular pathways including 
cellular  proliferation,  metabolism,  inflammation  and  longevity 
during  oxidative  stress  through  a  novel  family  of  transcription 
factors.  The  mammalian  forkhead  transcription  factors  of  the 
O  class  (FoxOs)  offer  exciting  prospects  for  multiple  disorders 
and  are  intimately  associated  with  several  vital  signal  transduc-
tion pathways, such as protein kinase B and Wingless, as well as 
growth factors, such as erythropoietin and insulin growth factor. 
Yet,  caution  must  be  exercised  with  these  transcription  factors 
since FoxOs not only can promote stem cell development, cardio-
vascular function and cellular longevity as well as control cancer 
progression, but they also may lead to unwanted apoptotic cell 
injury and metabolic complications. Furthermore, as we learn that 
particular pathways may control multiple cellular functions, Junior 
et al. also demonstrate that different tissues and regions of the 
body may be more susceptible to oxidative stress. For example, the 
induction of protective pathways against reactive oxygen species 
in specific tissues may not always correlate with regions that are 
most at risk. These authors show that detrimental lipid peroxida-
tion can increase in the striatum and cortex during seizures and 
oxidative stress, but protective pathways associated with superoxide 
dismutase may only increase in the cortex of the brain and exclude 
other vulnerable regions that involve the striatum. In any event, 
it  appears  clear  that  cellular  antioxidant  defenses  appear  to  be 
important to prevent clinical disease as suggested by the work of 
Gomes et al. Their work implicates that the increased expression 
of renal superoxide dismutase and catalase during nicotinamide 
adenine dinucleotide phosphate oxidase elevations with aging may 
actually prevent hypertension and impairment of cardiac function. 
Interestingly,  in  other  studies  that  examine  aging  with  cardio-
protective  regimens  against  oxidative  stress,  Vessey  et  al.  show 
that post-conditioning with ischemic/reperfusion injury was less 
affected by the aging process than pre-conditioning although both 
temporal treatments responded well with sphingosine 1-phosphate 
treatment. The work of these authors may suggest that additional 
cellular pathways during the aging process come into play that 
can affect cellular survival during oxidative stress in tissues such 
as those of the cardiovascular system. Furthermore, other agents 
such as manganese also may be essential to function as antioxi-
dants during events that involve tissue cryopreservation to provide 
new directions for fertility treatments as shown by the work with 
Cheema et al. for sperm cryopreservation. In contrast, new work 
by Khoobchandani et al. indicates that oxidative stress pathways 
are sometimes required to control unregulated cellular proliferation 
with cancer as demonstrated with the agent Chenopodium album. 
As we look more to clinical applications, Rael et al. illustrate that 
agents such as phthalate esters that are used to soften storage bags 
for packed red blood cells may during prolonged storage ultimately 
lead  to  oxidative  stress,  cytokine  release  and  inflammation  in 
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patients receiving transfusions. However, it should be recognized 
as described with the mammalian forkhead transcription factors   
in  this  issue  of  Oxidative  Medicine  and  Cellular  Longevity  that 
cellular pathways tied to oxidative stress also may have opposing 
roles. Rajapakse et al. in their Extra View article show that although 
O-linked  β-N-acetylglucosamine  has  been  previously  suggested 
during  hyperglycemia  to  lead  to  cardiac  dysfunction,  O-linked 
β-N-acetylglucosamine  also  may  prevent  cellular  inflammation 
in conjunction with having pro-oxidative properties. This work, 
in conjunction with our other articles in this issue of Oxidative 
Medicine and Cellular Longevity, provides further insight into the 
basis and treatment for numerous disorders tied to oxidative stress, 
but also brings us closer to understanding our initial discussion 
in regards to the immune system and the ability of microglia to 
choose to either assist or assassinate cells of the brain.
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